Transactions by PROVECTUS BIOPHARMACEUTICA-A (PVCT) in the last 6 months
Provectus Biopharmaceuticals, Inc. announced that it will receive $15,000,000 in a round of funding on October 15, 2014. The company will issue common shares and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. Network 1 Financial Securities, Inc. will act as the placement agent to the transaction. The company will pay 10% commission of the aggregate purchase ...
|No competitor information is available for PVCT.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|